Taffic Tablet (30’s) is a combination medication designed for the effective management of HIV-1 infection. Each tablet contains three active ingredients: Bictegravir (50mg), Emtricitabine (200mg), and Tenofovir Alafenamide (25mg). Bictegravir is an integrase strand transfer inhibitor that prevents the integration of viral DNA into the host genome, while Emtricitabine and Tenofovir Alafenamide are nucleoside reverse transcriptase inhibitors that block the reverse transcription process, thereby inhibiting viral replication. This powerful combination not only helps in reducing the viral load in the body but also aids in improving the immune system’s response to the infection. Taffic Tablet is typically prescribed as part of a comprehensive treatment plan for individuals diagnosed with HIV, and it is crucial for patients to adhere to their prescribed regimen to achieve optimal therapeutic outcomes.